- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07317687
Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
August 11, 2026 updated by: Dana Bechtold, West Virginia University
Rapid HIV, Hepatitis C, and Syphilis Screening in a Rural Street Medicine Clinic in West Virginia
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges.
Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results.
This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits.
Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing.
All participants will be invited to complete a brief survey about the experiences with screening methods.
The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dana Bechtold, DO
- Phone Number: 304-535-6343
- Email: dana.bechtold@hsc.wvu.edu
Study Locations
-
-
West Virginia
-
Harpers Ferry, West Virginia, United States, 25425
- Recruiting
- WVU Department of Family Medicine - Eastern Division
-
Contact:
- Dana Bechtold, DO
- Phone Number: 304-535-4108
- Email: dana.bechtold@hsc.wvu.edu
-
Principal Investigator:
- Dana Bechtold, DO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Participants will include patients in Berkeley and Jefferson Counties of West Virginia who visit the WVU Medicine Street Medicine Clinic.
Description
Inclusion Criteria:
- Patients of the WVU Medicine Street Medicine team
Exclusion Criteria:
- Patients under the age of 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Participants receiving fingerstick test
|
Fingerstick test for HIV, Hepatitis B and C, and Syphilis that gives results within 10-20 minutes
|
|
Participants receiving blood-draw test
Participants receiving blood-draw test:
|
Blood draw to test for HIV, Hepatitis B & C, and syphilis which can take up to 3 days for results
|
|
Participants who decline screening
Participants who decline screening: • Will be invited to answer survey questions about the feelings and experiences with screening (about 15-30 minutes). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Finger Stick
Time Frame: Day 1
|
Percentage of participants that opted to take the rapid finger stick test.
|
Day 1
|
|
Percentage of Blood Draw
Time Frame: Day 1
|
Percentage of participants that opted to take the blood draw test.
|
Day 1
|
|
Percentage that decline screening
Time Frame: Day 1
|
Percentage of participants that opted to decline screening
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dana Bechtold, DO, West Virginia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 21, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Study Registration Dates
First Submitted
December 19, 2025
First Submitted That Met QC Criteria
December 19, 2025
First Posted (Actual)
January 5, 2026
Study Record Updates
Last Update Posted (Actual)
August 13, 2026
Last Update Submitted That Met QC Criteria
August 11, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Infections
- RNA Virus Infections
- Virus Diseases
- Digestive System Diseases
- Liver Diseases
- Hepatitis, Viral, Human
- Communicable Diseases
- Sexually Transmitted Diseases
- DNA Virus Infections
- Flaviviridae Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Gram-Negative Bacterial Infections
- Spirochaetales Infections
- Hepadnaviridae Infections
- Hepatitis
- Sexually Transmitted Diseases, Bacterial
- Treponemal Infections
- Hepatitis B
- Hepatitis C
- Syphilis
- Investigative Techniques
- Specimen Handling
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Punctures
- Surgical Procedures, Operative
- Blood Specimen Collection
Other Study ID Numbers
- 2507193944
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.